BioCardia, Inc. (BCDA)
1.11
+0.03
(+2.78%)
USD |
NASDAQ |
Sep 08, 16:00
1.12
+0.01
(+0.90%)
Pre-Market: 20:00
BioCardia Price to Book Value : 6.160 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 6.160 |
| September 04, 2026 | 5.994 |
| September 03, 2026 | 6.049 |
| September 02, 2026 | 6.160 |
| September 01, 2026 | 6.105 |
| August 31, 2026 | 6.327 |
| August 28, 2026 | 6.382 |
| August 27, 2026 | 6.493 |
| August 26, 2026 | 6.604 |
| August 25, 2026 | 6.271 |
| August 24, 2026 | 5.883 |
| August 21, 2026 | 5.605 |
| August 20, 2026 | 5.367 |
| August 19, 2026 | 5.500 |
| August 18, 2026 | 5.413 |
| August 17, 2026 | 5.217 |
| August 14, 2026 | 5.404 |
| August 13, 2026 | 5.155 |
| August 12, 2026 | 4.884 |
| August 11, 2026 | 5.173 |
| August 10, 2026 | 5.367 |
| August 07, 2026 | 5.429 |
| August 06, 2026 | 5.27 |
| August 05, 2026 | 5.272 |
| August 04, 2026 | 5.051 |
| Date | Value |
|---|---|
| August 03, 2026 | 4.613 |
| July 31, 2026 | 4.574 |
| July 30, 2026 | 4.279 |
| July 29, 2026 | 4.294 |
| July 28, 2026 | 4.337 |
| July 27, 2026 | 4.486 |
| July 24, 2026 | 4.718 |
| July 23, 2026 | 5.022 |
| July 22, 2026 | 5.028 |
| July 21, 2026 | 5.116 |
| July 20, 2026 | 5.021 |
| July 17, 2026 | 4.583 |
| July 16, 2026 | 4.745 |
| July 15, 2026 | 4.863 |
| July 14, 2026 | 4.451 |
| July 13, 2026 | 5.051 |
| July 10, 2026 | 5.077 |
| July 09, 2026 | 4.953 |
| July 08, 2026 | 5.357 |
| July 07, 2026 | 5.633 |
| July 06, 2026 | 6.493 |
| July 02, 2026 | 6.660 |
| July 01, 2026 | 6.604 |
| June 30, 2026 | 6.882 |
| June 29, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cytokinetics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 3.633 |
| Alnylam Pharmaceuticals, Inc. | 25.69 |
| Anika Therapeutics, Inc. | 2.051 |
| Savara, Inc. | 7.907 |
Price to Book Value Related Metrics
| Price | 1.11 |
| Earnings Yield | -68.74% |
| Market Cap | 16.63M |